Evidence map›Paper›PMID 42466198›Full record

ArticleClinical kidney journal2026

Histological and clinical phenotypes of diabetic kidney disease: a baseline analysis of the HEROIC study.

Gordon G Paterson, Ortensia Vito, Lauren Heptinstall, Michael Sheaff, Abigail Lee, David Kim, Benjamin Challis, Robert Unwin, Magdi Yaqoob, Kieran McCafferty and 1 more

Abstract read
In one paragraph

Article in Clinical kidney journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gordon G PatersonCentre for Kidney and Bladder Health, Department of Renal Medicine, UCL, London, UK.ORCID https://orcid.org/0009-0006-0087-3081
Ortensia VitoTranslational Science and Clinical Development, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca BioPharmaceuticals R&D, Cambridge, UK.
Lauren HeptinstallDepartment of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Michael SheaffBart's Health NHS Trust, London, UK.
Abigail LeeBart's Health NHS Trust, London, UK.
David KimGenentech Inc, San Francisco, CA, USA.
Benjamin ChallisTranslational Science and Clinical Development, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca BioPharmaceuticals R&D, Cambridge, UK.
Robert UnwinCentre for Kidney and Bladder Health, Department of Renal Medicine, UCL, London, UK.ORCID https://orcid.org/0000-0001-7839-6031
Magdi YaqoobBart's Health NHS Trust, London, UK.
Kieran McCaffertyBart's Health NHS Trust, London, UK.
Ben CaplinCentre for Kidney and Bladder Health, Department of Renal Medicine, UCL, London, UK.ORCID https://orcid.org/0000-0001-9544-164X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diabetic kidney disease (DKD) is increasingly recognized as a heterogeneous condition. Our understanding of the structure-function relationships underpinning DKD is limited. The East and North London Diabetes Cohort (HEROIC) study aims to identify prognostic markers in a diverse DKD cohort. We present here the baseline clinical phenotype of the cohort, define clusters of DKD and assess the performance of estimated GFR (eGFR) equations including CKD Epi 2021. Methods: Patients with diabetes and CKD were recruited from two tertiary renal units. Renal biopsies were assessed using the Renal Pathology Society scoring system. Ordinal logistic regression was used to assess clinical associations with histological severity and ensemble consensus clustering was used to identify distinct phenotypes. eGFR bias was calculated as measured GFR-eGFR. Results: In our cohort of 188 DKD patients (9.0% Black, 46.3% South Asian, 14.9% White, and 29.8% other ethnicity), there was an inverse relationship between BMI and glomerular lesion severity (OR 0.93, Conclusions: We demonstrate clinically distinct clusters of DKD, which may provide hypotheses for 'personalized' approaches to interventions in DKD in future trials. We demonstrate that CKD-Epi 2021 performs poorly in a multi-ethnic DKD population.

Indexed as

CKDCKD-EPI equationdiabetic kidney diseaseGFRkidney biopsy

Identifiers

PMID42466198
PMCPMC13373966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.